InterVenn Biosciences
InterVenn is a medical diagnostics company developing artificially intelligence driven mass spectrometry platform for discovery and validation.
5
Funding Rounds
$250.9m
Money raised
Overview
InterVenn is a medical diagnostics company developing artificially intelligence driven mass spectrometry platform for discovery and validation.
-
Website:
- Business model: B2C B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company InterVenn Biosciences has raised a total of $244.4m in funding over 5 rounds.
Key Insights:
- InterVenn Series C round, August 2021: $201m
- Venn Biosciences Corp Series B round, November 16, 2020: $34m
- Venn Biosciences Corp Series A round, December 12, 2018: $9.4m
- Venn Biosciences Corp funding round, October 2018: $6.5m
InterVenn Series C round, August 2021
$201m
Venn Biosciences Corp Series B round, November 16, 2020
$34m
Venn Biosciences Corp Series A round, December 12, 2018
$9.4m
Venn Biosciences Corp funding round, October 2018
$6.5m
Industries
InterVenn Biosciences is active in the following industries: